layout.fixed.naaccr.doc.naaccr25.brafMutationalAnalysis.html Maven / Gradle / Ivy
                 Go to download
                
        
                    Show more of this group  Show more artifacts with this name
Show all versions of layout Show documentation
                Show all versions of layout Show documentation
Framework that allows defining file formats (layouts) and use them to read and write data files.
                
             The newest version!
        
        
  
    Item # 
    Length 
    Source of Standard 
    Year Implemented 
    Version Implemented 
    Year Retired 
    Version Retired 
   
  
    3940 
    1 
    NAACCR 
    2021 
    21 
     
     
   
NAACCR XML: Tumor.brafMutationalAnalysis
Description
The BRAF oncoprotein is involved in transmitting cell growth and proliferation signals from KRAS and NRAS. The BRAF V600E mutation is associated with poorer prognosis and predicts lack of response to anti-EGFR therapies.
Rationale
BRAF mutational analysis is recommended in clinical guidelines for patients with advanced colorectal cancer as a prognostic marker and factor in determining appropriate therapy.  It is a new data item for cases diagnosed 1/1/2021+.
Codes
        0 Normal  
 BRAF negative, BRAF wild type  
 Negative for (somatic) mutations, no alterations, no (somatic) mutations identified, not present, not detected  
        1 Abnormal (mutated)/detected: BRAF V600E (c.1799T>A) mutation  
        2 Abnormal (mutated)/detected, but not BRAF V600E (c.1799T>A) mutation  
        3 Abnormal (mutated)/detected, KIAA1549: BRAF gene fusion  
        4 Abnormal (mutated), NOS  
        7 Test ordered, results not in chart  
        8 Not applicable: Information not collected for this case  
If this information is required by your standard setter, use of code 8 may result in an edit error.)  
        9 Not documented in medical record  
BRAF not assessed or unknown if assessed  
        Blank Diagnosis year is prior to 2021  
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.
    © 2015 - 2025 Weber Informatics LLC | Privacy Policy